|
⚲
|
| Keyboard |
| Avant Diagnostics Inc
✚
|
|
|---|---|
| CIK # | 0001451929 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001451929] | |
| 10-Q | [0001451929] | |
| 3 | [0001451929] | |
| 4 | [0001451929] | |
| 8-K | [0001451929] | |
| D | [0001451929] | |
| SC 13D | [0001451929] | |
| SC 13G | [0001451929] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Avant Diagnostics Inc | Oncbiomune Pharmaceuticals Inc | [2020-06-15] |
| Coastal Investment Partners LLC | Avant Diagnostics Inc | [2018-10-26] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Avant Diagnostics Inc AVDX
Series A Preferred Stock · derivative
|
2018-08-23 | Grant | 25,000 | $1.00 | 25,000 |
|
Avant Diagnostics Inc AVDX
Series A Preferred Stock · derivative
|
2018-08-20 | Grant | 50,000 | $1.00 | 50,000 |
|
Avant Diagnostics Inc AVDX
Common Stock
|
2017-08-23 | Sell | 1,000,000 | $0.02 | 20,000 |
|
Avant Diagnostics Inc AVDX
Common Stock
|
2017-08-09 | Sell | 1,000,000 | $0.02 | 20,000 |